Chronic pain patients, overlooked in opioid crisis, getting new attention from top at FDA
The Food and Drug Administration is working to address how the opioid epidemic response has affected chronic pain patients, who often can't get relief.
Source: PsycPORT.com - Category: Psychiatry Source Type: news
More News: Chronic Pain | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Pain | Psychiatry